pentoxifylline has been researched along with Acute Relapsing Multiple Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bisaga, GN | 1 |
| Odinak, MM | 1 |
| Boĭko, AN | 1 |
| Mel'nik, IuB | 1 |
| Popova, NF | 1 |
| Pede, PD | 1 |
| Visintini, D | 1 |
| Telera, A | 1 |
| Cucurachi, L | 1 |
| Campanini, C | 1 |
| Immovilli, P | 1 |
| Vescovini, R | 1 |
| Sansoni, P | 1 |
2 trials available for pentoxifylline and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
[Possibilities of treatment of multiple sclerosis exacerbations without corticosteroids: a role of metabolic and antioxidant therapy].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antioxidants; Autoantibodies; Cognition; Disease Progres | 2011 |
Immunomodulatory effects of IFN-beta1a treatment alone or associated with pentoxifylline in patients with relapsing-remitting multiple sclerosis (RRMS).
Topics: Cells, Cultured; Female; Humans; Interferon-beta; Interferon-gamma; Interleukin-10; Interleukin-2; M | 2005 |